Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Investment firm PAG pays $540mm for majority ownership of Hisun BioRay

Executive Summary

Private equity firm PAG will pay $540mm to take a majority stake (58%) in Hisun BioRay Biopharmaceutical Co., a division of Zhejiang Hisun Pharmaceutical Co. Ltd. (which retains a 42% ownership).
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Buy-out
    • Partial Acquisition
    • Payment Includes Cash

Related Companies